Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC, 82400-82401 [2023-25947]
Download as PDF
<![CDATA[
82400
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 23, 2024. Such
persons may also file a written request
for a hearing on the application on or
before January 23, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1292]
Bulk Manufacturer of Controlled
Substances Application: Isosciences,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Isosciences, LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
SUMMARY:
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on October 25, 2023,
Isosciences, LLC, 340 Mathers Road,
Ambler, Pennsylvania 19002–3420,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Cathinone .....................................................................................................................................................................................
Methcathinone ..............................................................................................................................................................................
Lysergic acid diethylamide ...........................................................................................................................................................
Marihuana .....................................................................................................................................................................................
Tetrahydrocannabinols .................................................................................................................................................................
3,4-Methylenedioxyamphetamine .................................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................................
3,4-Methylenedioxymethamphetamine .........................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ..............................................................................................................................................
Alpha-methyltryptamine ................................................................................................................................................................
Bufotenine ....................................................................................................................................................................................
Diethyltryptamine ..........................................................................................................................................................................
Dimethyltryptamine .......................................................................................................................................................................
Psilocybin .....................................................................................................................................................................................
Psilocyn ........................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ..........................................................................................................................................
Dihydromorphine ..........................................................................................................................................................................
Heroin ...........................................................................................................................................................................................
Nicocodeine ..................................................................................................................................................................................
Nicomorphine ...............................................................................................................................................................................
Normorphine .................................................................................................................................................................................
Thebacon ......................................................................................................................................................................................
Normethadone ..............................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ..............................................................................................
Para-Fluorofentanyl ......................................................................................................................................................................
3-Methylfentanyl ...........................................................................................................................................................................
Alpha-methylfentanyl ....................................................................................................................................................................
Acetyl-alpha-methylfentanyl .........................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ....................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................................
Butyryl Fentanyl ............................................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................................
Beta-hydroxyfentanyl ....................................................................................................................................................................
Beta-hydroxy-3-methylfentanyl .....................................................................................................................................................
Alpha-methylthiofentanyl ..............................................................................................................................................................
3-Methylthiofentanyl .....................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..........................................................................
Thiofentanyl ..................................................................................................................................................................................
Beta-hydroxythiofentanyl ..............................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .......................................................................................
Amphetamine ...............................................................................................................................................................................
Methamphetamine ........................................................................................................................................................................
Codeine ........................................................................................................................................................................................
Dihydrocodeine .............................................................................................................................................................................
Oxycodone ...................................................................................................................................................................................
Hydromorphone ............................................................................................................................................................................
Hydrocodone ................................................................................................................................................................................
Isomethadone ...............................................................................................................................................................................
Methadone ....................................................................................................................................................................................
Methadone intermediate ...............................................................................................................................................................
VerDate Sep<11>2014
21:46 Nov 22, 2023
Jkt 262001
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
E:\FR\FM\24NON1.SGM
24NON1
1235
1237
7315
7360
7370
7400
7404
7405
7431
7432
7433
7434
7435
7437
7438
7439
9145
9200
9309
9312
9313
9315
9635
9811
9812
9813
9814
9815
9816
9821
9822
9824
9825
9830
9831
9832
9833
9834
9835
9836
9843
1100
1105
9050
9120
9143
9150
9193
9226
9250
9254
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
82401
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices
Drug
code
Controlled substance
Morphine .......................................................................................................................................................................................
Thebaine .......................................................................................................................................................................................
Levo-alphacetylmethadol ..............................................................................................................................................................
Oxymorphone ...............................................................................................................................................................................
Thiafentanil ...................................................................................................................................................................................
Alfentanil .......................................................................................................................................................................................
Sufentanil ......................................................................................................................................................................................
Carfentanil ....................................................................................................................................................................................
Fentanyl ........................................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
analytical testing. In reference to drug
codes 7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetics. No other activities for
these drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–25947 Filed 11–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1294]
Importer of Controlled Substances
Application: VHG Labs DBA LGC
Standards
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
VHG Labs DBA LGC
Standards has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 26, 2023. Such
persons may also file a written request
for a hearing on the application on or
before December 26, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
SUMMARY:
In
accordance with 21 CFR 1301.34(a), this
is notice that on November 6, 2023,
VHG Labs DBA LGC Standards, 3
Perimeter Road, Manchester, New
Hampshire 03103–3341, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
Drug code
Amineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) ........................................................
Mesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) ..............................................
3-Fluoro-N-methylcathinone (3-FMC) .....................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) 1238 I N .....................................................................................................................
Pentedrone (a-methylaminovalerophenone) ..........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) .......................................................................................................................................
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478 I N ..............................................................................
N,N-Dimethylamphetamine ....................................................................................................................................................
Fenethylline ............................................................................................................................................................................
4-Methylaminorex (cis isomer) ...............................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).
Mecloqualone .........................................................................................................................................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ....................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................................
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ....
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ........................................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .......................
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...............
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .......................................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...........................................
21:46 Nov 22, 2023
Jkt 262001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Controlled substance
VerDate Sep<11>2014
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
E:\FR\FM\24NON1.SGM
24NON1
Schedule
1219
1227
1233
1238
1246
1249
1478
1480
1503
1590
1595
I
I
I
I
I
I
I
I
I
I
I
2572
7010
7011
7012
7019
7021
7023
7024
7025
7031
7034
7041
7042
7049
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 88, Number 225 (Friday, November 24, 2023)]
[Notices]
[Pages 82400-82401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25947]
[[Page 82400]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1292]
Bulk Manufacturer of Controlled Substances Application:
Isosciences, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Isosciences, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
January 23, 2024. Such persons may also file a written request for a
hearing on the application on or before January 23, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on October 25, 2023, Isosciences, LLC, 340 Mathers Road,
Ambler, Pennsylvania 19002-3420, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cathinone.............................. 1235 I
Methcathinone.......................... 1237 I
Lysergic acid diethylamide............. 7315 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
3,4-Methylenedioxyamphetamine.......... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine.. 7404 I
3,4-Methylenedioxymethamphetamine...... 7405 I
5-Methoxy-N-N-dimethyltryptamine....... 7431 I
Alpha-methyltryptamine................. 7432 I
Bufotenine............................. 7433 I
Diethyltryptamine...................... 7434 I
Dimethyltryptamine..................... 7435 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine.... 7439 I
Dihydromorphine........................ 9145 I
Heroin................................. 9200 I
Nicocodeine............................ 9309 I
Nicomorphine........................... 9312 I
Normorphine............................ 9313 I
Thebacon............................... 9315 I
Normethadone........................... 9635 I
Acryl fentanyl (N-(1-phenethylpiperidin- 9811 I
4-yl)-N-phenylacrylamide).
Para-Fluorofentanyl.................... 9812 I
3-Methylfentanyl....................... 9813 I
Alpha-methylfentanyl................... 9814 I
Acetyl-alpha-methylfentanyl............ 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl....................... 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-
4-yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)- 9825 I
N-phenylacetamide.
Beta-hydroxyfentanyl................... 9830 I
Beta-hydroxy-3-methylfentanyl.......... 9831 I
Alpha-methylthiofentanyl............... 9832 I
3-Methylthiofentanyl................... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-phenylfuran-
2-carboxamide).
Thiofentanyl........................... 9835 I
Beta-hydroxythiofentanyl............... 9836 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Isomethadone........................... 9226 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
[[Page 82401]]
Morphine............................... 9300 II
Thebaine............................... 9333 II
Levo-alphacetylmethadol................ 9648 II
Oxymorphone............................ 9652 II
Thiafentanil........................... 9729 II
Alfentanil............................. 9737 II
Sufentanil............................. 9740 II
Carfentanil............................ 9743 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in analytical testing. In reference to drug codes 7360 (Marihuana) and
7370 (Tetrahydrocannabinols), the company plans to bulk manufacture
these drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-25947 Filed 11-22-23; 8:45 am]
BILLING CODE P
